Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / Fund iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer Blackrock
Entity holding fund iShares VII Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF Ticker CUS1(GBX) LSE
ETF Ticker CUSS(USD) LSE
ETF Ticker SXRG(EUR) F
ETF Ticker CSUSS.MI(EUR) CXE
ETF Ticker CSUSSz(USD) CXE
ETF Ticker CUSS.LS(USD) CXE
ETF Ticker CSUSS(EUR) ETF Plus
ETF Ticker CUS1.L(GBP) LSE
ETF Ticker CUSS.L(GBP) LSE

Holdings detail for TRML

Stock Name	Tourmaline Bio Inc.
Ticker	TRML(USD) NASDAQ
TYPE	Common Stock
Country	USA

Show aggregate TRML holdings

News associated with TRML

Truist Financial Downgrades Tourmaline Bio (NASDAQ:TRML) to Hold: Tourmaline Bio (NASDAQ:TRML – Get Free Report) was downgraded by equities research analysts at Truist Financial from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Wednesday, Marketbeat Ratings reports. They presently have a $48.00 price target on the stock, down from their previous price target of […] - 2025-09-11 05:14:52
Stocks Settle Higher on Hopes of Accelerated Fed Rate Cuts: The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed up +0.27%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.43%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.33%. September E-mini S&P futures (ESU25 ) rose +0.28%, and September E-mini Nasdaq futures... - 2025-09-10 13:24:04
Stocks Settle Higher on Hopes of Accelerated Fed Rate Cuts: The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed up +0.27%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.43%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.33%. September E-mini S&P futures (ESU25 ) rose +0.28%, and September E-mini Nasdaq futures... - 2025-09-10 11:56:00
Stocks Settle Higher on Hopes of Accelerated Fed Rate Cuts: The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed up +0.27%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.43%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.33%. September E-mini S&P futures (ESU25 ) rose +0.28%, and September E-mini Nasdaq futures... - 2025-09-10 10:14:58
Stocks Settle Higher on Hopes of Accelerated Fed Rate Cuts: The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed up +0.27%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.43%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.33%. September E-mini S&P futures (ESU25 ) rose +0.28%, and September E-mini Nasdaq futures... - 2025-09-10 08:35:12
Stocks Settle Higher on Hopes of Accelerated Fed Rate Cuts: The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed up +0.27%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.43%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.33%. September E-mini S&P futures (ESU25 ) rose +0.28%, and September E-mini Nasdaq futures... - 2025-09-10 06:54:32
Stocks Settle Higher on Hopes of Accelerated Fed Rate Cuts: The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed up +0.27%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.43%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.33%. September E-mini S&P futures (ESU25 ) rose +0.28%, and September E-mini Nasdaq futures... - 2025-09-10 03:39:30
Tourmaline Bio, Inc. (NASDAQ:TRML) Receives $50.14 Average Target Price from Analysts: Shares of Tourmaline Bio, Inc. (NASDAQ:TRML – Get Free Report) have been assigned an average rating of “Moderate Buy” from the eight analysts that are presently covering the firm, Marketbeat Ratings reports. Four research analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average […] - 2025-09-10 02:32:51
Stocks Settle Higher on Hopes of Accelerated Fed Rate Cuts: The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed up +0.27%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.43%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.33%. September E-mini S&P futures (ESU25 ) rose +0.28%, and September E-mini Nasdaq futures... - 2025-09-10 00:27:19
Stocks Edge Higher on Expectations for Fed Rate Cuts: The S&P 500 Index ($SPX ) (SPY ) today is up +0.13%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.11%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.19%. September E-mini S&P futures (ESU25 ) are up +0.07%, and September E-mini Nasdaq futures... - 2025-09-09 14:59:32
Stocks Turn Mixed as US Job Growth Less Than Previously Stated: The S&P 500 Index ($SPX ) (SPY ) today is up +0.02%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.07%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.08%. September E-mini S&P futures (ESU25 ) are down -0.08%, and September E-mini Nasdaq futures... - 2025-09-09 14:45:23
Stocks Edge Higher on Expectations for Fed Rate Cuts: The S&P 500 Index ($SPX ) (SPY ) today is up +0.13%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.11%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.19%. September E-mini S&P futures (ESU25 ) are up +0.07%, and September E-mini Nasdaq futures... - 2025-09-09 12:48:35
Tourmaline Bio Agrees To Be Acquired By Novartis In $1.4 Bln Deal; Stock Up: (RTTNews) - Tourmaline Bio Inc. (TRML) announced Tuesday that it has agreed to be acquired by Novartis AG (NVS, NOVN.SW) for $48.00 per share in cash at closing, representing a total equity value of about $1.4 billion. The deal price represents a premium of 59% to Tourmalines clo - 2025-09-09 02:28:03
Federated Hermes Inc. Buys 120,322 Shares of Tourmaline Bio, Inc. (NASDAQ:TRML): Federated Hermes Inc. increased its stake in shares of Tourmaline Bio, Inc. (NASDAQ:TRML – Free Report) by 13,036.0% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 121,245 shares of the company’s stock after acquiring an additional 120,322 shares during the quarter. Federated Hermes Inc.’s […] - 2025-08-06 05:13:00
Tourmaline Bio, Inc. (NASDAQ:TRML) Receives $49.33 Consensus PT from Analysts: Tourmaline Bio, Inc. (NASDAQ:TRML – Get Free Report) has received an average rating of “Buy” from the seven analysts that are presently covering the firm, MarketBeat reports. Seven equities research analysts have rated the stock with a buy rating. The average 12 month price target among analysts that have covered the stock in the last […] - 2025-06-27 02:37:04
GAMMA Investing LLC Grows Stake in Tourmaline Bio, Inc. (NASDAQ:TRML): GAMMA Investing LLC grew its stake in shares of Tourmaline Bio, Inc. (NASDAQ:TRML – Free Report) by 4,481.7% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 7,514 shares of the company’s stock after acquiring an additional 7,350 shares during the quarter. GAMMA Investing LLC’s holdings in Tourmaline Bio were worth $114,000 at the […] - 2025-06-24 04:46:55
SG Americas Securities LLC Has $550,000 Stock Position in Tourmaline Bio, Inc. (NASDAQ:TRML): SG Americas Securities LLC lifted its position in Tourmaline Bio, Inc. (NASDAQ:TRML – Free Report) by 3.9% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 36,180 shares of the company’s stock after buying an additional 1,368 shares during the quarter. SG Americas […] - 2025-06-23 04:58:58
California State Teachers Retirement System Has $213,000 Stake in Tourmaline Bio, Inc. (NASDAQ:TRML): California State Teachers Retirement System increased its stake in shares of Tourmaline Bio, Inc. (NASDAQ:TRML – Free Report) by 527.9% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 10,505 shares of the company’s stock after buying an additional 8,832 shares during the quarter. California State Teachers Retirement System’s holdings in Tourmaline Bio were […] - 2025-06-13 05:02:51
Tourmaline Bio, Inc. (NASDAQ:TRML) Receives $49.33 Consensus PT from Brokerages: Tourmaline Bio, Inc. (NASDAQ:TRML – Get Free Report) has been given an average rating of “Buy” by the seven ratings firms that are covering the firm, Marketbeat.com reports. Seven analysts have rated the stock with a buy recommendation. The average 12 month price target among brokers that have issued ratings on the stock in the […] - 2025-06-02 03:09:00
Millennium Management LLC Has $7.40 Million Stock Holdings in Tourmaline Bio, Inc. (NASDAQ:TRML): Millennium Management LLC lowered its position in shares of Tourmaline Bio, Inc. (NASDAQ:TRML – Free Report) by 28.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 364,658 shares of the company’s stock after selling 144,757 shares during the quarter. Millennium […] - 2025-05-27 04:48:57
Head-To-Head Analysis: Tourmaline Bio (NASDAQ:TRML) vs. enGene (NASDAQ:ENGN): Tourmaline Bio (NASDAQ:TRML – Get Free Report) and enGene (NASDAQ:ENGN – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, profitability, analyst recommendations, valuation, institutional ownership, risk and dividends. Institutional & Insider Ownership 91.9% of Tourmaline Bio […] - 2025-05-14 02:20:48
Analysts Set Tourmaline Bio, Inc. (NASDAQ:TRML) Target Price at $49.33: Tourmaline Bio, Inc. (NASDAQ:TRML – Get Free Report) has been assigned a consensus rating of “Buy” from the seven brokerages that are covering the firm, Marketbeat Ratings reports. Seven equities research analysts have rated the stock with a buy recommendation. The average 12-month price target among brokers that have covered the stock in the last […] - 2025-05-08 02:04:55
Barclays PLC Acquires 26,733 Shares of Tourmaline Bio, Inc. (NASDAQ:TRML): Barclays PLC grew its holdings in shares of Tourmaline Bio, Inc. (NASDAQ:TRML – Free Report) by 84.0% during the fourth quarter, Holdings Channel reports. The firm owned 58,566 shares of the company’s stock after purchasing an additional 26,733 shares during the period. Barclays PLC’s holdings in Tourmaline Bio were worth $1,187,000 as of its most […] - 2025-05-05 05:18:49
Tourmaline Bio (NASDAQ:TRML) Earns Buy Rating from Analysts at Chardan Capital: Stock analysts at Chardan Capital began coverage on shares of Tourmaline Bio (NASDAQ:TRML – Get Free Report) in a report issued on Wednesday, Marketbeat reports. The brokerage set a “buy” rating and a $70.00 price target on the stock. Chardan Capital’s price objective would indicate a potential upside of 304.16% from the company’s current price. […] - 2025-04-25 04:24:47
Vanguard Group Inc. Acquires 43,652 Shares of Tourmaline Bio, Inc. (NASDAQ:TRML): Vanguard Group Inc. boosted its stake in shares of Tourmaline Bio, Inc. (NASDAQ:TRML – Free Report) by 4.1% in the 4th quarter, HoldingsChannel reports. The fund owned 1,106,125 shares of the company’s stock after buying an additional 43,652 shares during the quarter. Vanguard Group Inc.’s holdings in Tourmaline Bio were worth $22,432,000 at the end […] - 2025-04-16 04:28:51
Head to Head Survey: Tourmaline Bio (NASDAQ:TRML) vs. Vaxcyte (NASDAQ:PCVX): Vaxcyte (NASDAQ:PCVX – Get Free Report) and Tourmaline Bio (NASDAQ:TRML – Get Free Report) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, valuation, institutional ownership, risk, profitability, dividends and analyst recommendations. Profitability This table compares Vaxcyte and Tourmaline Bio’s net […] - 2025-02-21 04:34:51

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc TRML holdings

Date	Number of TRML Shares Held	Base Market Value of TRML Shares	Local Market Value of TRML Shares	Change in TRML Shares Held	Change in TRML Base Value	Current Price per TRML Share Held	Previous Price per TRML Share Held

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of TRML by Blackrock for IE00B3VWM098

Show aggregate share trades of TRML

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-10-15 BUY 372 47.890 47.920 47.917 USD 17,825 20.26
2025-10-07 BUY 62 47.890 47.905 47.903 USD 2,970 19.83
2025-10-02 BUY 62 47.870 47.940 47.933 USD 2,972 19.39
2025-09-30 BUY 124 47.830 47.900 47.893 USD 5,939 19.10
2025-09-24 BUY 124 47.750 47.760 47.759 USD 5,922 18.48
2025-09-16 BUY 124 47.710 47.720 47.719 USD 5,917 18.16
2025-09-11 BUY 248 47.600 47.640 47.636 USD 11,814 17.84
2025-09-04 BUY 186 25.100 25.530 25.487 USD 4,741 17.68
2025-08-29 BUY 248 23.400 23.420 23.418 USD 5,808 17.58
2025-08-27 BUY 124 23.515 24.560 24.455 USD 3,032 17.51
2025-08-26 SELL -4,165 23.505 23.580 23.572 USD -98,179 17.48 Loss of -25,383 on sale
2025-08-21 SELL -77 23.060 23.070 23.069 USD -1,776 17.38 Loss of -438 on sale
2025-08-15 BUY 770 22.570 22.900 22.867 USD 17,608 17.29
2025-08-06 SELL -154 21.940 22.305 22.269 USD -3,429 17.17 Loss of -786 on sale
2025-08-04 SELL -154 21.590 22.050 22.004 USD -3,389 17.11 Loss of -754 on sale
2025-07-31 BUY 231 22.130 23.510 23.372 USD 5,399 17.04
2025-07-28 SELL -77 22.610 22.950 22.916 USD -1,765 16.93 Loss of -461 on sale
2025-07-25 SELL -77 19.770 20.270 20.220 USD -1,557 16.91 Loss of -255 on sale
2025-06-30 SELL -154 15.990 16.740 16.665 USD -2,566 16.82 Profit of 24 on sale
2025-06-25 SELL -77 16.990 17.230 17.206 USD -1,325 16.82 Loss of -29 on sale
2025-06-20 SELL -154 16.640 17.100 17.054 USD -2,626 16.82 Loss of -35 on sale
2025-05-23 BUY 77 15.320 15.370 15.365 USD 1,183 16.66
2025-05-19 SELL -77 16.630 16.700 16.693 USD -1,285 16.69 Loss of 0 on sale
2025-05-15 SELL -231 15.520 15.700 15.682 USD -3,623 16.70 Profit of 235 on sale
2025-05-12 SELL -77 15.780 16.190 16.149 USD -1,243 16.73 Profit of 45 on sale
2025-05-09 SELL -77 15.100 16.320 16.198 USD -1,247 16.75 Profit of 43 on sale
2025-04-30 SELL -77 17.210 17.700 17.651 USD -1,359 16.80 Loss of -66 on sale
2025-04-24 SELL -154 17.320 17.840 17.788 USD -2,739 16.80 Loss of -153 on sale
2025-04-17 SELL -77 16.010 16.110 16.100 USD -1,240 16.80 Profit of 54 on sale
2025-04-15 SELL -231 14.930 15.260 15.227 USD -3,517 16.85 Profit of 374 on sale
2025-04-14 SELL -231 14.090 14.300 14.279 USD -3,298 16.88 Profit of 601 on sale
2025-04-09 SELL -312 12.475 13.050 12.993 USD -4,054 17.05 Profit of 1,266 on sale
2025-04-07 SELL -546 12.620 13.270 13.205 USD -7,210 17.17 Profit of 2,167 on sale
2025-04-04 BUY 6,474 12.830 13.120 13.091 USD 84,751 17.23
2025-03-31 BUY 55 15.210 16.220 16.119 USD 887 17.36
2025-03-19 SELL -110 16.480 18.059 17.901 USD -1,969 17.41 Loss of -54 on sale
2025-03-14 SELL -330 18.800 18.820 18.818 USD -6,210 17.37 Loss of -476 on sale
2025-03-13 SELL -110 17.040 17.180 17.166 USD -1,888 17.38 Profit of 24 on sale
2025-03-12 SELL -1,870 16.270 16.360 16.351 USD -30,576 17.40 Profit of 1,961 on sale
2025-03-07 SELL -110 14.380 15.660 15.532 USD -1,709 17.53 Profit of 220 on sale
2025-03-06 SELL -165 14.330 14.440 14.429 USD -2,381 17.59 Profit of 521 on sale
2025-03-03 SELL -55 12.330 13.280 13.185 USD -725 17.89 Profit of 259 on sale
2025-02-28 SELL -330 13.090 13.100 13.099 USD -4,323 17.98 Profit of 1,611 on sale
2025-02-26 SELL -55 12.940 13.340 13.300 USD -732 18.19 Profit of 269 on sale
2025-02-25 SELL -165 12.550 12.720 12.703 USD -2,096 18.31 Profit of 926 on sale
2025-02-18 BUY 275 13.140 14.580 14.436 USD 3,970 19.00
2025-02-13 BUY 55 13.090 13.745 13.679 USD 752 19.42
2025-02-12 BUY 55 13.230 13.250 13.248 USD 729 19.58
2025-02-11 BUY 165 12.880 13.760 13.672 USD 2,256 19.77
2025-02-06 BUY 495 14.990 16.100 15.989 USD 7,915 20.24
2025-01-27 BUY 55 17.000 18.080 17.972 USD 988 21.45
2025-01-22 SELL -110 17.640 18.040 18.000 USD -1,980 21.96 Profit of 436 on sale
2025-01-17 SELL -55 18.000 18.195 18.175 USD -1,000 22.56 Profit of 241 on sale
2025-01-16 BUY 55 17.330 18.540 18.419 USD 1,013 22.84
2025-01-14 BUY 165 18.600 20.075 19.928 USD 3,288 23.36
2025-01-13 BUY 110 19.470 19.700 19.677 USD 2,164 23.60
2025-01-08 BUY 330 20.000 20.350 20.315 USD 6,704 24.45
2024-12-30 BUY 275 20.080 20.460 20.422 USD 5,616 25.20
2024-12-06 BUY 220 25.930 26.230 26.200 USD 5,764 25.11
2024-12-05 BUY 55 24.030 26.430 26.190 USD 1,440 25.27
2024-12-04 BUY 275 25.585 25.960 25.922 USD 7,129 25.21
2024-11-29 BUY 275 26.040 26.645 26.585 USD 7,311 25.05
2024-11-27 BUY 220 25.660 26.780 26.668 USD 5,867 23.82
2024-11-26 BUY 55 23.820 23.960 23.946 USD 1,317 0.00
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-10-15	BUY	372	47.890	47.920	47.917	USD 17,825	20.26
2025-10-07	BUY	62	47.890	47.905	47.903	USD 2,970	19.83
2025-10-02	BUY	62	47.870	47.940	47.933	USD 2,972	19.39
2025-09-30	BUY	124	47.830	47.900	47.893	USD 5,939	19.10
2025-09-24	BUY	124	47.750	47.760	47.759	USD 5,922	18.48
2025-09-16	BUY	124	47.710	47.720	47.719	USD 5,917	18.16
2025-09-11	BUY	248	47.600	47.640	47.636	USD 11,814	17.84
2025-09-04	BUY	186	25.100	25.530	25.487	USD 4,741	17.68
2025-08-29	BUY	248	23.400	23.420	23.418	USD 5,808	17.58
2025-08-27	BUY	124	23.515	24.560	24.455	USD 3,032	17.51
2025-08-26	SELL	-4,165	23.505	23.580	23.572	USD -98,179	17.48 Loss of -25,383 on sale
2025-08-21	SELL	-77	23.060	23.070	23.069	USD -1,776	17.38 Loss of -438 on sale
2025-08-15	BUY	770	22.570	22.900	22.867	USD 17,608	17.29
2025-08-06	SELL	-154	21.940	22.305	22.269	USD -3,429	17.17 Loss of -786 on sale
2025-08-04	SELL	-154	21.590	22.050	22.004	USD -3,389	17.11 Loss of -754 on sale
2025-07-31	BUY	231	22.130	23.510	23.372	USD 5,399	17.04
2025-07-28	SELL	-77	22.610	22.950	22.916	USD -1,765	16.93 Loss of -461 on sale
2025-07-25	SELL	-77	19.770	20.270	20.220	USD -1,557	16.91 Loss of -255 on sale
2025-06-30	SELL	-154	15.990	16.740	16.665	USD -2,566	16.82 Profit of 24 on sale
2025-06-25	SELL	-77	16.990	17.230	17.206	USD -1,325	16.82 Loss of -29 on sale
2025-06-20	SELL	-154	16.640	17.100	17.054	USD -2,626	16.82 Loss of -35 on sale
2025-05-23	BUY	77	15.320	15.370	15.365	USD 1,183	16.66
2025-05-19	SELL	-77	16.630	16.700	16.693	USD -1,285	16.69 Loss of 0 on sale
2025-05-15	SELL	-231	15.520	15.700	15.682	USD -3,623	16.70 Profit of 235 on sale
2025-05-12	SELL	-77	15.780	16.190	16.149	USD -1,243	16.73 Profit of 45 on sale
2025-05-09	SELL	-77	15.100	16.320	16.198	USD -1,247	16.75 Profit of 43 on sale
2025-04-30	SELL	-77	17.210	17.700	17.651	USD -1,359	16.80 Loss of -66 on sale
2025-04-24	SELL	-154	17.320	17.840	17.788	USD -2,739	16.80 Loss of -153 on sale
2025-04-17	SELL	-77	16.010	16.110	16.100	USD -1,240	16.80 Profit of 54 on sale
2025-04-15	SELL	-231	14.930	15.260	15.227	USD -3,517	16.85 Profit of 374 on sale
2025-04-14	SELL	-231	14.090	14.300	14.279	USD -3,298	16.88 Profit of 601 on sale
2025-04-09	SELL	-312	12.475	13.050	12.993	USD -4,054	17.05 Profit of 1,266 on sale
2025-04-07	SELL	-546	12.620	13.270	13.205	USD -7,210	17.17 Profit of 2,167 on sale
2025-04-04	BUY	6,474	12.830	13.120	13.091	USD 84,751	17.23
2025-03-31	BUY	55	15.210	16.220	16.119	USD 887	17.36
2025-03-19	SELL	-110	16.480	18.059	17.901	USD -1,969	17.41 Loss of -54 on sale
2025-03-14	SELL	-330	18.800	18.820	18.818	USD -6,210	17.37 Loss of -476 on sale
2025-03-13	SELL	-110	17.040	17.180	17.166	USD -1,888	17.38 Profit of 24 on sale
2025-03-12	SELL	-1,870	16.270	16.360	16.351	USD -30,576	17.40 Profit of 1,961 on sale
2025-03-07	SELL	-110	14.380	15.660	15.532	USD -1,709	17.53 Profit of 220 on sale
2025-03-06	SELL	-165	14.330	14.440	14.429	USD -2,381	17.59 Profit of 521 on sale
2025-03-03	SELL	-55	12.330	13.280	13.185	USD -725	17.89 Profit of 259 on sale
2025-02-28	SELL	-330	13.090	13.100	13.099	USD -4,323	17.98 Profit of 1,611 on sale
2025-02-26	SELL	-55	12.940	13.340	13.300	USD -732	18.19 Profit of 269 on sale
2025-02-25	SELL	-165	12.550	12.720	12.703	USD -2,096	18.31 Profit of 926 on sale
2025-02-18	BUY	275	13.140	14.580	14.436	USD 3,970	19.00
2025-02-13	BUY	55	13.090	13.745	13.679	USD 752	19.42
2025-02-12	BUY	55	13.230	13.250	13.248	USD 729	19.58
2025-02-11	BUY	165	12.880	13.760	13.672	USD 2,256	19.77
2025-02-06	BUY	495	14.990	16.100	15.989	USD 7,915	20.24
2025-01-27	BUY	55	17.000	18.080	17.972	USD 988	21.45
2025-01-22	SELL	-110	17.640	18.040	18.000	USD -1,980	21.96 Profit of 436 on sale
2025-01-17	SELL	-55	18.000	18.195	18.175	USD -1,000	22.56 Profit of 241 on sale
2025-01-16	BUY	55	17.330	18.540	18.419	USD 1,013	22.84
2025-01-14	BUY	165	18.600	20.075	19.928	USD 3,288	23.36
2025-01-13	BUY	110	19.470	19.700	19.677	USD 2,164	23.60
2025-01-08	BUY	330	20.000	20.350	20.315	USD 6,704	24.45
2024-12-30	BUY	275	20.080	20.460	20.422	USD 5,616	25.20
2024-12-06	BUY	220	25.930	26.230	26.200	USD 5,764	25.11
2024-12-05	BUY	55	24.030	26.430	26.190	USD 1,440	25.27
2024-12-04	BUY	275	25.585	25.960	25.922	USD 7,129	25.21
2024-11-29	BUY	275	26.040	26.645	26.585	USD 7,311	25.05
2024-11-27	BUY	220	25.660	26.780	26.668	USD 5,867	23.82
2024-11-26	BUY	55	23.820	23.960	23.946	USD 1,317	0.00

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of TRML

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	43,837	34	100,251	43.7%
2025-09-18	67,782	131	487,086	13.9%
2025-09-17	76,555	11	180,554	42.4%
2025-09-16	29,513	333	98,581	29.9%
2025-09-15	70,034	61	229,955	30.5%
2025-09-12	68,336	128	223,154	30.6%
2025-09-11	108,055	1,447	313,824	34.4%
2025-09-10	107,221	5,190	545,010	19.7%
2025-09-09	2,215,993	7,886	8,384,880	26.4%
2025-09-08	137,882	67	328,349	42.0%
2025-09-05	94,112	0	199,582	47.2%
2025-09-04	89,183	0	120,776	73.8%
2025-09-03	88,575	0	113,165	78.3%
2025-09-02	49,504	0	56,256	88.0%
2025-08-29	42,240	0	49,473	85.4%
2025-08-28	20,280	4	28,865	70.3%
2025-08-27	38,845	0	52,650	73.8%
2025-08-26	31,462	0	42,618	73.8%
2025-08-25	16,134	0	21,952	73.5%
2025-08-22	23,826	0	36,715	64.9%
2025-08-21	24,859	701	39,322	63.2%
2025-08-20	14,552	18	24,244	60.0%
2025-08-19	26,999	0	34,332	78.6%
2025-08-18	86,635	12	124,816	69.4%
2025-08-15	15,384	47	32,478	47.4%
2025-08-14	21,143	150	37,702	56.1%
2025-08-13	25,778	178	38,032	67.8%
2025-08-12	30,079	29	46,958	64.1%
2025-08-11	25,110	12	105,206	23.9%
2025-08-08	32,996	1,085	93,345	35.3%
2025-08-07	42,833	0	54,084	79.2%
2025-08-06	35,063	0	68,011	51.6%
2025-08-05	29,480	16	46,585	63.3%
2025-08-04	19,548	73	71,736	27.2%
2025-08-01	42,562	28	87,355	48.7%
2025-07-31	72,288	56	135,590	53.3%
2025-07-30	60,324	202	95,902	62.9%
2025-07-29	312,855	233	432,374	72.4%
2025-07-28	95,697	51	250,795	38.2%
2025-07-25	49,673	16	115,227	43.1%
2025-07-24	26,079	374	91,334	28.6%
2025-07-23	17,642	0	46,233	38.2%
2025-07-22	14,460	348	27,164	53.2%
2025-07-21	18,966	203	24,327	78.0%
2025-07-18	19,195	0	40,338	47.6%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Stock Name / Fund	iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer	Blackrock
Entity holding fund	iShares VII Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300Q7FFITMZ2PFZ28
ETF Ticker	CUS1(GBX) LSE
ETF Ticker	CUSS(USD) LSE
ETF Ticker	SXRG(EUR) F
ETF Ticker	CSUSS.MI(EUR) CXE
ETF Ticker	CSUSSz(USD) CXE
ETF Ticker	CUSS.LS(USD) CXE
ETF Ticker	CSUSS(EUR) ETF Plus
ETF Ticker	CUS1.L(GBP) LSE
ETF Ticker	CUSS.L(GBP) LSE